ReviewBiological research2026
Alternatives for fetal bovine serum (FBS) and sustainability of milk derivatives in cell culture.
Review in Biological research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fetal bovine serum (FBS) is frequently used as a media supplement in cell cultures, as it contains many nutrients, growth factors, and hormones crucial to sustaining cell growth in vitro. However, over the years, concerns about its use have been highlighted. The unknown composition, batch-to-batch variability, and increasing demand and prices have raised scientific and economic issues. In addition, the collection procedure has raised ethical concerns. These issues have prompted researchers worldwide to explore more sustainable and reproducible alternatives performing like FBS. In this review, we examine several potential FBS substitutes, derived from other animal sources or chemically defined sera. Among the considered alternatives, milk emerges as a relevant and suitable option, helping to steer the biotechnological progress towards a more ethical and sustainable approach. Food waste is a globally widespread problem, and milk is no exception. Its use as an alternative supplement for cell cultures could contribute to a reduction in food waste and in the FBS usage, limiting the drawbacks associated with it. Furthermore, milk is often referred to as the “perfect food” as it is rich in nutrients fundamental to sustaining growth, resembling FBS characteristics. Bovine milk derivatives have proven effective in reducing and, in some cases, fully replacing FBS, therefore representing an interesting and feasible option as supplements for culture media. Considering that, requalified milk could help address both social and economic needs and, through circular economy strategies, reduce costs for the biotechnological industry and enhance environmental sustainability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.